Drawing for TLC

USPTO serial 97057179

TLC

Reviewed by CopyMark Law Group

Reg. 7129501Status 700Registered
Filing date
Status date
Registration date
Aug 8, 2023
Examiner
ADEYIGA, ADETAYO JANET
Law office
TMEG LAW OFFICE 109

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TLC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joe McKinney Muncy

Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 LEGATO RD SUITE 310FAIRFAX, VA 22033UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Allergy medications; Antibacterial pharmaceuticals; Antibiotic preparations; Antibiotics; Antifungal preparations; Anti-cancer preparations; Anti-diabetic preparations; Anti-inflammatories; Aspirin; Cardiovascular treatment preparations; Cells for medical or clinical use; Chemotherapeutics; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medicated skin care preparations; Ophthalmic preparations; Pain relief medication; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Radioactive pharmaceutical preparations for therapeutic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 8, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 8, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 24, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 30, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 30, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 30, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 27, 2022GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 27, 2022GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 27, 2022CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 26, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 19, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 7, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 6, 2022DOCKASSIGNED TO EXAMINER—
Nov 4, 2021TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Nov 4, 2021PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 29, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance